Halozyme Therapeutics Inc (NASDAQ:HALO)

17.82
Delayed Data
As of May 27
 +0.08 / +0.45%
Today’s Change
7.51
Today|||52-Week Range
18.18
+84.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Patton John Stuart
Director
Sale8/19/201475,000$9.96$747.0K+77.84%
Kelley Kenneth J
Director
Sale3/05/201540,000$15.33$613.2K+15.79%
Torley Helen I
President & Chief Executive Officer
Buy9/16/201450,000$8.92$446.0K+97.12%
Engler Robert L
Director
Sale8/14/201435,000$9.96$348.6K+78.74%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201425,000$8.90$222.5K+97.12%
Engler Robert L
Director
Buy8/14/201475,000$2.05$153.8K+78.74%
Patton John Stuart
Director
Buy8/19/201475,000$2.05$153.8K+77.84%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201511,919$10.06$119.9K+77.14%
Ramsay David A
Chief Financial Officer & Vice President
Buy9/16/201450,000$2.05$102.5K+97.12%
Ramsay David A
Chief Financial Officer & Vice President
Sale12/22/20146,621$9.46$62.6K+91.00%
Page of 3

To view my watchlist

Not a member yet?

Sign up now for a free account